Comparison of the effects of subconjunctival and topical anti-VEGF therapy (bevacizumab) on experimental corneal neovascularization

Autor: Ozgul Altintas, Ozdemir Ozdemir, Levent Altintaş, Nurşen Yüksel, Cigdem Akdag, Berna Özkan
Rok vydání: 2014
Předmět:
Male
genetic structures
medicine.medical_treatment
Disease models
animal

Neovascularization
Cornea
Random Allocation
lcsh:Ophthalmology
Injeções
Medicine
Saline
Ratos
Anti vegf
Corneal Diseases
Antibodies
Monoclonal

General Medicine
Inibidores de angiogênese/administração & dosagem
Bevacizumab
Vascular endothelial growth factor A
Anesthesia
Modelos animais de doenças
Cauterization
Corneal neovascularization/chemically induced
medicine.symptom
Injections
Intraocular

medicine.drug
medicine.medical_specialty
Corneal diseases
Antibodies
Monoclonal
Humanized

Injections
Angiogenesis inhibitors/administration and dosage
Ophthalmology
Animals
Corneal Neovascularization
Neovascularização da córnea/induzido quimicamente
Rats
Wistar

business.industry
Animais
medicine.disease
eye diseases
Rats
Disease Models
Animal

lcsh:RE1-994
Fator A de crescimento do endotélio vascular
Corneal neovascularization
Histopathology
sense organs
business
Doenças da córnea
Zdroj: Arquivos Brasileiros de Oftalmologia v.77 n.4 2014
Arquivos brasileiros de oftalmologia
Conselho Brasileiro de Oftalmologia (CBO)
instacron:CBO
Arquivos Brasileiros de Oftalmologia, Volume: 77, Issue: 4, Pages: 209-213, Published: AUG 2014
Arquivos Brasileiros de Oftalmologia, Vol 77, Iss 4, Pp 209-213 (2014)
Arquivos Brasileiros de Oftalmologia, Vol 77, Iss 4, Pp 209-213
ISSN: 1678-2925
Popis: Purpose: To compare the effects of bevacizumab applied either subconjunctivally or topically, in a rat model of corneal neovascularization induced by alkali burn. Methods: The right corneas of 24 Wistar-Albino rats were cauterized with silver nitrate sticks. The rats were divided randomly and equally into three groups: no treatment control (n=8), subconjunctival bevacizumab treatment (n=8), and topical bevacizumab treatment (n=8). Immediately following cauterization, the subconjunctival group was treated with a 0.05 ml (1.25 mg) bevacizumab subconjunctival injection. The topical group was treated with 10 mg/ml bevacizumab twice daily, and the control group received subconjunctival saline injections twice daily. The burn stimulus and neovascularization scores were evaluated using a technique previously described by Mahoney and Waterbury. Digital photographs were obtained before the eyes were enucleated and corneal sections were then analyzed by histopathology. Results: The mean burn stimulus score was 1.86 ± 0.6 and there was no statistical difference between the groups (p=0.730). The mean neovascularization scores in the subconjunctival and topical bevacizumab groups were statistically lower than the control group (p
Databáze: OpenAIRE